Ropharma Bras Total Liabilities
Ropharma Bras total liabilities. Based on the latest financial reports, Ropharma Bras (RPH) has total liabilities worth RON688.42 Million RON (≈ $158.07 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See RPH defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Ropharma Bras (2021–2025)
Total liabilities of Ropharma Bras from 2021 to 2025. This chart illustrates how Ropharma Bras's total liabilities have evolved over time, based on quarterly financial data.
Ropharma Bras Competitors by Total Liabilities
The table below lists competitors of Ropharma Bras ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
|
USA | $10.85 Million |
|
Artea SA
PA:ARTE
|
France | €236.12 Million |
|
Centric Holdings S.A
AT:CENTR
|
Greece | €11.16 Million |
|
Bhagyanagar India Limited
NSE:BHAGYANGR
|
India | Rs3.77 Billion |
|
Qleanair Holding AB
ST:QAIR
|
Sweden | Skr348.48 Million |
|
Varengold Bank AG
F:VG8
|
Germany | €1.03 Billion |
|
Lyka Labs Limited
NSE:LYKALABS
|
India | Rs664.32 Million |
|
Apex Equity Holdings Bhd
KLSE:5088
|
Malaysia | RM161.18 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Ropharma Bras's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Ropharma Bras's balance sheet.
Liquidity & Leverage Metrics
Ropharma Bras Total Liabilities Ratios Explained
Ropharma Bras total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.73 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ropharma Bras's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ropharma Bras (2021–2025)
The table below shows the annual total liabilities of Ropharma Bras from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | RON688.42 Million ≈ $158.07 Million |
+23.83% |
| 2024-06-30 | RON555.92 Million ≈ $127.65 Million |
+3.57% |
| 2023-06-30 | RON536.76 Million ≈ $123.25 Million |
+121.43% |
| 2022-06-30 | RON242.40 Million ≈ $55.66 Million |
-5.17% |
| 2021-06-30 | RON255.62 Million ≈ $58.69 Million |
-- |
About Ropharma Bras
S.C. Ropharma S.A., together with its subsidiaries, operates a chain of pharmacies in Romania. The company offers medicines on prescription, over-the-counter (OTC) medications, food supplements, dermato-cosmetics, cosmetics, and medical devices, as well as other healthcare products dispensed through pharmacies. It also provides medical services in various areas, including oncology, hematology, on… Read more